Your time starts now — translation time lines for major ophthalmic discoveries

David A Mackey
Med J Aust 2012; 196 (11): . || doi: 10.5694/mja11.11322
Published online: 18 June 2012

Key performance indicators for medical research do not always indicate the long-term success of a treatment

Translation into reduced morbidity and mortality is the ultimate measure of success for medical research. However, this may take decades and often researchers are dead before the full impact of their research is realised. Gregor Mendel’s research is an excellent example, with the most important publication in genetics remaining uncited for 30 years.1 The key performance indicators for medical research are publications and their citations — the number of papers published in peer-reviewed journals, the number of times these publications are cited, and the impact factor of the journal in which they are published.2

  • Centre for Ophthalmology and Visual Science and Lions Eye Institute, University of Western Australia, Perth, WA.


Competing interests:

No relevant disclosures.

  • 1. Sorsby A. Gregor Mendel. Br Med J 1965; 1: 333-338.
  • 2. Cartwright VA, McGhee CN. Ophthalmology and vision science research. Part 1: Understanding and using journal impact factors and citation indices. J Cataract Refract Surg 2005; 31: 1999-2007.
  • 3. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 257: 491-496.
  • 4. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475.
  • 5. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851.
  • 6. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941; 3: 35-46.
  • 7. Wainwright M, Swan HT. C. G. Paine and the earliest surviving clinical records of penicillin therapy. Med Hist 1986; 30: 42-56.
  • 8. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
  • 9. Algire GH, Chalkley HW, Legallais FY, Park HD. Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 1945; 6: 73-85.
  • 10. Aiello LP, George DJ, Cahill MT, et al. Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. Ophthalmology 2002; 109: 1745-1751.
  • 11. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444.
  • 12. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431.
  • 13. Stone EM. A very effective treatment for neovascular macular degeneration [editorial]. N Engl J Med 2006; 355: 1493-1495.
  • 14. Meyer-Schwickerath G. [Light coagulation; a method for treatment and prevention of the retinal detachment] [German]. Albrecht Von Graefes Arch Ophthalmol 1954; 156: 2-34.
  • 15. O’Malley P. Portable xenon arc light coagulator. Br J Ophthalmol 1973; 57: 935-944.
  • 16. Maiman TH. Stimulated optical radiation in ruby [letter]. Nature 1960; 187: 493-494.
  • 17. Hoye RC, Minton JP. The noble gas ion laser as a light-knife. Surg Forum 1965; 16: 93-95.
  • 18. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81: 383-396.
  • 19. Ridley H. Intra-ocular acrylic lenses; a recent development in the surgery of cataract. Br J Ophthalmol 1952; 36: 113-122.
  • 20. Jaffe NS. The introduction of IOL: how the struggle for lens implants’ acceptance was won. Cataract Refract Surg Today 2005 ;Oct: 32-35.
  • 21. Jaffe NS. Cataract surgery — a modern attitude toward a technologic explosion. N Engl J Med 1978; 299: 235-237.
  • 22. Ohba N, Nakao K. The 101 most frequently cited articles in ophthalmology journals from 1850 to 1949. Arch Ophthalmol 2010; 128: 1610-1617.
  • 23. Mackey DA. 2005 Gregg Lecture: Congenital cataract — from rubella to genetics. Clin Experiment Ophthalmol 2006; 34: 199-207.
  • 24. Tyndall J. The optical deportment of the atmosphere in relation to the phenomena of putrefaction and infection. Philos Trans R Soc Lond B Biol Sci 1876; 166: 27-74.
  • 25. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929; 10: 226-236.
  • 26. Sorsby A. Ophthalmia neonatorum. Br J Vener Dis 1950; 26: 57-62.
  • 27. Chain E, Florey HW, Gardner AD, et al. Penicillin as a chemotherapeutic agent. Lancet 1940; 236: 226-228.
  • 28. Florey HL. Howard Walter Florey interviewed by Hazel de Berg in the Hazel de Berg collection [sound recording]. Canberra: National Library of Australia, 1967.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.